The next petition on the agenda is PE1592, by Shaheen McQuade, on group B strep information and testing. Members will recall that the UK national screening committee’s review of the latest evidence on screening for group B strep was published in March 2017. It has not recommended introducing a national screening programme for the disease.
At our previous consideration of the petition, we agreed to write to the Scottish Government, seeking its view on that decision. The Scottish Government’s response stated that
“the National Institute of Health Research has been asked to commission a UK-wide clinical trial to compare universal screening for GBS against usual-risk-based care. We hope this will commence as soon as practicable.”
The Scottish Government’s letter also noted that
“the UK Government Chief Scientific Adviser held two research workshops last year to bring together a broad range of experts on GBS from across the UK.”
It is intended that an outcome paper will be published following those meetings, which will outline steps that are intended to aid in reducing the harm that is caused by group B strep.
We have not had any written submissions from the petitioner, although she has been invited to provide them. Nevertheless, we can conclude that the Scottish and UK Governments are taking forward measures that, it is to be hoped, will address the issues that are raised by the petitioner. Do members have any comments or suggestions on actions that we can take?